Skip to main content
. 2022 Nov 15;207(10):1310–1323. doi: 10.1164/rccm.202204-0629OC

Table 1.

Patients’ Demographics

Age, years 66 (62–75)
Sex, female, no. (%) 2 (13)
Height, cm 175 (170–178)
Body mass index, kg/m2 28 (24–30)
SAPS II 31 (29–37)
SOFA at study inclusion 2 (2–2)
COVID-19 as the cause of respiratory failure 10 (67)
Hematological malignancies, no.(%) 3 (20)
Duration of Non-Invasive respiratory support before enrollment, hours  
 Non-Invasive Ventilation 0 (0–0)
 Continuous Positive Airway Pressure 0 (0–0)
 High Flow Nasal Oxygen 0 (0–12)
Bilateral infiltrates at study inclusion 14 (93)
PaO2/FiO2 during face mask O2 120 (103–137)
PaCO2 during face mask O2 34 (27–36)
Glasgow Coma Scale score on inclusion 15 (15–15)
Treatment failure after the enrollment – need for endotracheal intubation, no. (%) 4 (27)
Length of ICU stay, days 13 (5–19)
In-ICU mortality no. (%) 6 (40)

Data are reported as medians (Interquartile range), unless specified otherwise.